Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

SHA:688298 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,434	5,666	7,209	12,955	27,660	24,360
Market Cap Growth	-17.95%	-21.40%	-44.35%	-53.16%	13.55%	-
Enterprise Value	1,976	2,695	2,201	5,922	22,133	23,281
Last Close Price	22.95	29.33	35.76	61.58	127.17	109.69
PE Ratio	-	-	-	6.27	5.62	14.52
Forward PE	-	2.00	2.00	1.94	-	-
PS Ratio	5.31	6.85	8.79	1.48	2.72	7.46
PB Ratio	0.67	0.80	0.96	1.56	4.01	9.94
P/TBV Ratio	0.76	0.93	1.04	1.69	4.11	10.02
P/FCF Ratio	-	-	-	6.66	5.89	14.65
P/OCF Ratio	-	-	-	4.32	5.32	13.61
EV/Sales Ratio	2.36	3.26	2.68	0.68	2.18	7.13
EV/EBITDA Ratio	-	-	-	2.53	3.78	11.53
EV/EBIT Ratio	-	-	-	2.62	3.80	11.57
EV/FCF Ratio	-	-	-	3.05	4.71	14.00
Debt / Equity Ratio	0.05	0.08	0.08	0.01	0.00	-
Debt / EBITDA Ratio	-	-	-	0.04	0.00	-
Debt / FCF Ratio	-	-	-	0.04	0.00	-
Asset Turnover	0.10	-	0.08	0.89	1.62	1.66
Inventory Turnover	0.05	-	1.65	11.43	6.30	3.28
Quick Ratio	3.55	-	5.01	3.57	3.66	2.61
Current Ratio	4.04	-	5.43	3.84	3.95	2.98
Return on Equity (ROE)	-7.92%	-7.01%	-5.27%	27.58%	105.79%	124.21%
Return on Assets (ROA)	-4.31%	-	-4.19%	14.36%	57.97%	63.91%
Return on Capital (ROIC)	-4.70%	-4.48%	-4.98%	18.45%	77.73%	92.02%
Return on Capital Employed (ROCE)	-	-	-	26.80%	84.10%	81.80%
Earnings Yield	-12.62%	-9.03%	-5.51%	15.96%	17.79%	6.89%
FCF Yield	-	-	-36.64%	15.01%	16.98%	6.83%
Dividend Yield	-	-	-	2.71%	2.89%	2.28%
Payout Ratio	-	-	-	35.89%	10.26%	1.51%
Buyback Yield / Dilution	3.03%	2.50%	-0.13%	0.02%	-2.16%	-30.20%
Total Shareholder Return	-	2.50%	-0.13%	2.73%	0.73%	-27.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.